Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02225808 · ClinicalTrials.gov registry record · NA

Neural Mechanisms of CBT for Anxiety in Autism (Open Pilot Study)

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT02225808 is a NA study that has completed, run by Yale University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02225808, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This is an open, pilot study of neural mechanisms of cognitive-behavioral therapy for anxiety in children with high-functioning autism spectrum disorder (ASD). In addition to the core symptoms, approximately forty percent of children with ASD exhibit clinically significant levels of anxiety. Cognitive-Behavioral Therapy (CBT) is a promising treatment for anxiety in children with high-functioning ASD, but the neural mechanisms of this treatment have not been studied. CBT teaches emotion regulation skills such as cognitive reappraisal, followed by behavioral exposure to anxiety-provoking situations. The investigators propose to investigate the neural mechanisms of CBT for anxiety by evaluating fMRI indices of socioemotional functioning before and after treatment in children, ages 8 to 14, with high-functioning ASD. Dysfunction of the amygdala and its connectivity with prefrontal cortex has been implicated in co-occurring ASD and anxiety. In the investigators research, compared to typically developing controls, children with ASD have shown lower activation in several regions of prefrontal cortex and a lack of down-regulation in the amygdala during a task of emotion regulation. Based on these observations, the investigators propose that a positive response to CBT for anxiety in children with ASD will be associated with increased activation of several regions in the prefrontal cortex as well as increased functional connectivity between prefrontal regions the amygdala during the task of emotion regulation. The primary aim of this pilot study is to examine the effects of CBT on the neural basis of anxiety in ASD by collecting fMRI data during emotion regulation, face perception, and rest before and after treatment. The investigators hypothesize that CBT will increase prefrontal activity, decrease amygdala reactivity, and enhance amygdala-prefrontal functional connectivity during emotion regulation. The investigators also hypothesize that CBT will decrease amygdala reactivi

Interventions

  • BEHAVIORAL CBT for anxiety in autism

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-08
Est. Completion 2016-12
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT02225808

The ClinicalTrials.gov registry entry for NCT02225808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CBT for anxiety in autism is the first listed.

NCT02225808 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02225808 about?

NCT02225808 is a clinical study titled "Neural Mechanisms of CBT for Anxiety in Autism (Open Pilot Study)". This is an open, pilot study of neural mechanisms of cognitive-behavioral therapy for anxiety in children with high-functioning autism spectrum disorder (ASD). In addition to the core symptoms, approximately forty percent of children with ASD exhibit clinically significant levels of anxiety. Cogniti...

What is the current status of trial NCT02225808?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-08. Estimated completion is 2016-12.

What interventions are being tested in trial NCT02225808?

The interventions under investigation include: CBT for anxiety in autism (BEHAVIORAL).

Who is sponsoring clinical trial NCT02225808?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.